...million to advance therapies targeting chromosomal instability to treat cancer. New investors Vida Ventures and Catalio Capital Management...

...Immunai raised $60 million in a series A round led by Schusterman Family Investments, Duquesne Family Office, Catalio Capital Management...

...Capital, Sands Capital, PFM Health Sciences, Windham Ventures, New Enterprise Associates, Innovatus Capital Partners and Catalio Capital Management.Hung’s...

...are four firms that debuted with their first biotech venture investments in 2020: Pureos Bioventures, Catalio Capital Management...

...million in a private round co-led by existing investor Apeiron Investment Group and new investor Catalio Capital Management...

...healthy and disease settings. Novartis Venture Fund, Eli Lilly and Co. (NYSE:LLY), AbbVie Ventures, Invus, Catalio Capital Management...
...raised: $81 millionInvestors: Third Rock, Novartis Venture Fund, Eli Lilly and Co., AbbVie Ventures, Invus, Catalio Capital Management...

...to biotech mezzanine rounds —Casdin Capital, Catalio Capital Management...

...round, which included new investors Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures and Catalio Capital Management...
...raised: $75.3 million Investors: Section 32, Temasek, DNS Capital, New Leaf Venture Partners, Waterman Ventures, Catalio Capital Management...